Economy
Alembic Pharma Reports 81% Net Profit Surge in Second Quarter
The Hindu2h
THE BRIEF
1
Alembic Pharmaceuticals reported an 81% year-on-year increase in consolidated net profit to ₹335 crore for the September quarter.
2
Revenue from operations grew by 36% to ₹2,603 crore, largely driven by strong volume growth and new product launches in the United States market.
3
The company is expanding its collaboration with DifGen Pharmaceuticals to focus on specialized dosage forms and complex injectables to strengthen its global pipeline.